Cardiovascular complications of immune checkpoint inhibitors

Cardiovascular complications of immune checkpoint inhibitors

Cardiovascular toxicity of cancer therapies remains an urgent problem today. The creation of highly effect antitumor drugs also means the appearance of new adverse effects. Immune checkpoint inhibitors (ICI) is a new class of antitumor drugs that is different from traditional chemotherapeutic and ta...

Full description

Bibliographic Details
Main Authors: A. A. Kulievа, E. I. Emelina, G. E. Gendlin, I. G. Nikitin, S. K. Zyryanov, S. I. Varentsov, I. I. Zakharova
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2020-04-01
Series:Качественная клиническая практика
Subjects:
кардиотоксичность
ингибиторы контрольных точек иммунитета
миокардит
кардиоонкология
Online Access:https://www.clinvest.ru/jour/article/view/477

Similar Items

Similar Items